A guardian molecule ensures that liver cells do not lose their identity. This has been discovered by researchers from the ...

HealthDay News — The absolute risk for thyroid cancer is low among patients receiving glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy, but risk is elevated in the first year of treatment, ...

By Dr. Priyom Bose, Ph.D. Short-term increase in thyroid cancer diagnoses observed with GLP-1RA initiation, likely driven by heightened case detection rather than new cancer development Study: GLP-1RA ...

Thyroid cancer recurrence risk was not elevated among patients with high-normal vs low-normal exposure to TSH following thyroidectomy.

Additionally, researchers have identified specific genetic markers that may help predict thyroid cancer risk in certain populations. Leading endocrinologists and primary care physicians emphasize ...

Women under 50 are now 82% more likely to be diagnosed with cancer than their male counterparts ... be attributed to the rise in breast and thyroid cancers, the study said, which now account ...

“Breast and thyroid cancer account for almost half of all cancer diagnoses in women younger than 50,” said Rebecca Siegel, lead author of the report and senior scientific director of ...

In the largest study of its kind involving a diabetic population, the use of glucagon-like peptide 1 receptor agonist (GLP-1 RA) drugs shows no significantly increased risk for thyroid cancer ...

Vascular invasion is present in 40% of cases, and the majority of the tumors progress outside of the thyroid ... were 2 important predictors of tumor growth and, hence, useful criteria in ...